News

Interview by BFM Business

Nathalie Vandenbroucke, Executive Director, and Richard Fabre, biologist, were the guests of the TV show on BFM Business on march 1

read more
May 2022 : Dendris publishes its results

May 2022 : Dendris publishes its results

We are pleased to announce the publication of our work "The DendrisCHIP Technology as a New, Rapid and Reliable Molecular Method for the Diagnosis of Osteoarticular Infections". See the publication

read more

Dendris accelerates

Initiated at the end of 2020, the automation of DendrisChip technology in microplate format is born! Performed on Hamilton platform, the automated solution can test up to 96 samples simultaneously, from PCR product purification to reading, in 3 hours.

read more

Dendris automates its process on the HAMILTON platform

Started in 2020, the development of the automated version of hybridization steps will be completed in 2021 in partnership with Hamilton. The automation of our solution is one of the priority points to fully meet the productivity needs of our testing laboratories. This...

read more
Dendris at RICAI on december 13th and 14th 2021  (Stand 35)

Dendris at RICAI on december 13th and 14th 2021 (Stand 35)

Dendris will be present at the RICAI at "Palais des Congrès" in Paris on December 13 and 14, 2021 Interdisciplinary Meeting of Anti-Infectious Chemotherapy 41st edition of the RICAI with a very varied program this year while emphasizing diagnostic and therapeutic...

read more

News

by | Feb 20, 2021